• PIN60 VISUALIZING THE IMMUNIZATION RATES IN NIGERIA: MAPPING THE CRISIS TO TARGET RESOURCES ALLOCATION

    May 1, 2020, 00:00
  • PIN86 PSYCHOMETRIC ASSESSMENT OF URDU VERSION OF BRIEF HIV WORLD HEALTH ORGANIZATION QUALITY OF LIFE INSTRUMENT IN PAKISTANI HIV/AIDS PATIENTS

    May 1, 2020, 00:00
  • PIN23 A MACHINE LEARNING BASED METAMODEL FOR COST-EFFECTIVENESS ANALYSIS OF HEPATITIS C TREATMENT

    May 1, 2020, 00:00
  • PIN27 EVALUATING THE COST-EFFECTIVENESS OF A SEQUENTIAL PNEUMOCOCCAL VACCINATION COMPARED TO SINGLE DOSE VACCINATION STRATEGY FOR ADULTS IN HONG KONG

    May 1, 2020, 00:00
  • PDB34 THE DIABETES PREVENTION PROGRAM (DPP) QUALITY OF WELL BEING (QWB) UTILITY MEASURES AND MISSING DATA CONSIDERATIONS: AVAILABLE CASE ANALYSIS (ACA) VS. MULTIPLE IMPUTATION (MI) RESULTS FOR UTILITIES AND QUALITY ADJUSTED LIFE YEARS (QALY ...

    May 1, 2020, 00:00
  • PIH28 MEASURING THE COST OF PRESSURE ULCERS AMONG US HOSPITAL PATIENTS: A CLUSTERING APPROACH

    May 1, 2020, 00:00
  • Gastrointestinal Disorders - Patient-Centered Research

    May 1, 2020, 00:00
  • PMH2 THE RELATIONSHIP BETWEEN MAJOR DEPRESSIVE DISORDER AND PHYSICAL COMORBIDITIES: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00
  • Infectious Diseases - Economic Evaluation

    May 1, 2020, 00:00
  • PMH22 INCREASING TOTAL COST OF CARE WITH ADDITIONAL STEPS OF THERAPY IN MAJOR DEPRESSIVE DISORDER

    May 1, 2020, 00:00
  • PMU54 ANALYSIS OF E-PRESCRIPTION SYSTEM AND AWARENESS OF PHARMACISTS ON REIMBURSEMENT PROGRAM IN UKRAINE

    May 1, 2020, 00:00
  • PMD44 HEALTHCARE RESOURCE UTILIZATION AND PAYMENTS AMONG PATIENTS RECEIVING TREATMENT FOR ACETABULUM FRACTURES

    May 1, 2020, 00:00
  • PCV58 DEFINING THROMBOEMBOLIC EVENTS USING ADMINISTRATIVE CLAIMS DATA

    May 1, 2020, 00:00
  • PDB78 RACIAL DIFFERENCES IN HEALTHCARE COSTS ASSOCIATED WITH OBESITY-RELATED MULTI-MORBIDITY IN THE UNITED STATES

    May 1, 2020, 00:00
  • PBI4 EVIDENCE REQUIREMENT TRENDS FOR SINGLE ARM STUDY SCENARIOS IN RARE DISEASE AND ONCOLOGY: WHAT ARE THE LESSONS FOR VALUE DEMONSTRATION?

    May 1, 2020, 00:00
  • PIN39 ECONOMIC EVALUATION OF THE NATIONAL AIDS PLAN RECOMMENDED GUIDELINES FOR COFORMULATED INITIAL ANTIRETROVIRAL THERAPY IN HIV-INFECTED ADULTS IN MEXICO IN 2018

    May 1, 2020, 00:00
  • PDG70 OPIOID USE IN CHRONIC NON-CANCER PAIN: ANALYSIS USING MEDICAL EXPENDITURE PANEL SURVEY (MEPS) DATABASE

    May 1, 2020, 00:00
  • Drugs Generics - Patient-Centered Research

    May 1, 2020, 00:00
  • PMS53 EPIDEMIOLOGICAL DISEASE BURDEN OF FEMORAL NECK FRACTURE BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00
  • PIH34 PREVALENCE OF ANEMIA AND IRON DEFICIENCY IN PREGNANT WOMEN LIVING IN CARTAGENA, COLOMBIA

    May 1, 2020, 00:00
  • PMS29 EARLY ECONOMIC EVALUATION DEMONSTRATES THAT ROBOTIC ASSISTED SURGERY IS COST-EFFECTIVE IN PATIENTS UNDERGOING UNICOMPARTMENTAL KNEE ARTHROPLASTY, A UK NATIONAL HEALTH SERVICE PERSPECTIVE

    May 1, 2020, 00:00
  • PGI15 COST PER REMISSION WITH VEDOLIZUMAB AND USTEKINUMAB FOR THE TREATMENT OF MODRATE TO SEVERELY ACTIVE CROHN'S DISEASE IN BRAZIL: PERSPECTIVE OF THE PRIVATE HEALTHCARE SYSTEM

    May 1, 2020, 00:00
  • PMH29 EXAMINING HEALTHCARE UTILIZATION AND COSTS ASSOCIATED WITH NEGATIVE SYMPTOMS OF SCHIZOPHRENIA AND SUBSTANCE ABUSE DISORDER USING REAL WORLD EVIDENCE DATA

    May 1, 2020, 00:00
  • PMD13 A REAL-WORLD COST-MINIMIZATION ANALYSIS COMPARING THE USE OF DIFFERENT ENDOSCOPIC STAPLERS IN THORACOSCOPIC LOBECTOMY

    May 1, 2020, 00:00
  • PMD48 ROBOTIC TOTAL HYSTERECTOMY: ASSOCIATION OF SURGICAL INDICATION WITH USE OF ROBOTIC-ASSISTANCE AND RELATED HEALTHCARE RESOURCE UTILIZATION AND COSTS

    May 1, 2020, 00:00
  • CC4 COST-EFFECTIVENESS ANALYSIS OF THE STEPPED EXERCISE PROGRAM FOR PATIENTS WITH KNEE OSTEOARTHRITIS (STEP-KOA) TRIAL

    May 1, 2020, 00:00
  • PIN65 ESTIMATING THE LIFETIME ECONOMIC BURDEN OF STREPTOCOCCUS SUIS AND ITS PRODUCTIVITY IMPACT IN THAILAND

    May 1, 2020, 00:00
  • PIN32 COST-UTILITY ANALYSIS OF NEW ANTIVIRAL TREATMENTS FOR NON-GENOTYPE 1 HEPATITIS C VIRUS IN CHINA: A SOCIETAL PERSPECTIVE

    May 1, 2020, 00:00
  • PMH16 DRUG EXPENDITURE, PRICE, AND UTILIZATION IN THE U.S. MEDICAID PROGRAM: AN EMPIRICAL TREND ANALYSIS FOR SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) AND SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIS) ANTIDEPRESSANTS FROM 1991 ...

    May 1, 2020, 00:00
  • PMD42 HEALTHCARE RESOURCE UTILIZATION AFTER TREATMENT WITH CEMENTED TOTAL KNEE ARTHTROPLASTY

    May 1, 2020, 00:00
  • PDB33 THE EFFECT OF DEPRESSION ON HEALTH CARE UTILIZATION AND HEALTH EXPENDITURE IN PATIENTS WITH DIABETES

    May 1, 2020, 00:00
  • Biologics/Biosimilars/Regenerative Medicine - Economic Evaluation

    May 1, 2020, 00:00
  • PMH36 THE RELATIONSHIP BETWEEN IRON DEFICIENCY ANAEMIA AND ANTENATAL DEPRESSION AMONG PREGNANT WOMEN

    May 1, 2020, 00:00
  • PMU18 ECONOMIC EVALUATION OF AN NT-PROBNP-SUPPORTED DIAGNOSTIC STRATEGY AMONG DYSPNEIC PATIENTS SUSPECTED OF ACUTE HEART FAILURE IN THE EMERGENCY DEPARTMENT

    May 1, 2020, 00:00
  • PMS44 THE ASSOCIATIONS BETWEEN PHYSICAL ACTIVITY AND COMORBIDITIES IN U.S OSTEOARTHRITIS PATIENTS: FINDINGS FROM THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 2007 TO 2010

    May 1, 2020, 00:00
  • Infectious Diseases - Patient-Centered Research

    May 1, 2020, 00:00
  • PMU35 MODELING POTENTIAL HEALTH GAINS AND HEALTH SYSTEM SAVINGS ASSOCIATED WITH VAPORIZED NICOTINE PRODUCTS IN CANADA

    May 1, 2020, 00:00
  • Mental Health - Patient-Centered Research

    May 1, 2020, 00:00
  • PDB74 EPIDEMIOLOGICAL DISEASE BURDEN OF NON-INSULIN-DEPENDENT DIABETES WITH MULTIPLE COMPLICATIONS BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00
  • PMS92 ECONOMIC AND CLINICAL BURDEN OF SYSTEMIC LUPUS ERYTHEMATOSUS IN LATIN AMERICA

    May 1, 2020, 00:00
  • PMD43 LENSX FEMTOSECOND LASER ASSISTED AND MANUAL CATARACT SURGERY: A REVIEW OF COMPARATIVE EFFECTIVENESS, SAFETY AND EFFICIENCY OUTCOMES

    May 1, 2020, 00:00
  • PIN58 HUMAN PAPILLOMAVIRUS VACCINE:ADVERSE EVENTS REPORTED TO THE US VACCINE ADVERSE EVENTS REPORTING SYSTEM (2010-2019)

    May 1, 2020, 00:00
  • PGI39 INFLAMMATORY BOWEL DISEASE PATIENT'S TREATMENT PREFERENCES - USING QUALITATIVE PATIENT SURVEY DATA TO DEVELOP A DISCRETE CHOICE EXPERIMENT

    May 1, 2020, 00:00
  • PGI34 ESTIMATING HEALTH-STATE UTILITY VALUES IN REFLUX ESOPHAGITIS USING THE EQ-5D-5L

    May 1, 2020, 00:00
  • PIN52 CAN BESIFLOXACIN USE DECREASE BACTERIAL CONJUNCTIVITIS BURDEN? - AN ESTIMATION VIA DYNAMIC TRANSMISSION MODELLING

    May 1, 2020, 00:00
  • PIN77 ASSESSING THE REAL-WORLD INPATIENT TREATMENT PARADIGM FOR RECURRENT CLOSTRIDIUM DIFFICILE

    May 1, 2020, 00:00
  • PIT7 DOES INTRAARTICULAR INVOLVEMENT INCREASE THE RISK OF COMPLICATIONS AFTER FRACTURE REPAIR SURGERY?

    May 1, 2020, 00:00
  • PMS77 PILOT INVESTIGATION OF THE QUALITY OF LIFE AND SOCIO-DEMOGRAPHIC FACTORS OF PATIENTS UNDERWENT TOTAL HIP ARTHROPLASTY IN THE PRIVATE HEALTH CARE SECTOR IN HUNGARY

    May 1, 2020, 00:00
  • PIT8 NEW INJURY SEVERITY SCORE: DOES IT INDEPENDENTLY PREDICT THE TREATMENT WITH INTRAMEDULLARY NAILING IN TIBIAL FRACTURES?

    May 1, 2020, 00:00
  • PMD9 COST-EFFECTIVENESS OF MOISTURE WICKING FABRIC IN THE TREATMENT OF INTERTRIGO COMPARED TO STANDARD OF CARE (SOC) IN A BRITISH CARE HOME SETTING USING A MARKOV DECISION MODEL

    May 1, 2020, 00:00
  • Objective Estimates of Direct-Medical Costs Among Persons Aged 3 to 38 Years With and Without Research-Defined Autism Spectrum Disorder Ascertained During Childhood: A Population-Based Birth-Cohort Study

    May 1, 2020, 00:00
  • PMD39 EFFICIENCY AND ECONOMIC ANALYSIS OF OPTICAL BIOMETERS: EXPERIENCE FROM A PRIVATE EYE MEDICAL CENTER IN THE UNITED STATES OF AMERICA

    May 1, 2020, 00:00
  • PMH48 HEPATITIS C TESTING AMONG FLORIDA MEDICAID BENEFICIARIES WITH SUBSTANCE USE DISORDERS

    May 1, 2020, 00:00
  • PMS49 EPIDEMIOLOGICAL DISEASE BURDEN OF SUBTROCHANTERIC FRACTURE BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00
  • PMS31 ANNUAL HEALTH INSURANCE TREATMENT COST OF INJURIES TO THE ANKLE AND FOOT BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00
  • PIN47 COMPARATIVE BUDGET IMPACT ANALYSIS OF PNEUMOCOCCAL VACCINES IN COLOMBIAN IMMUNIZATION PROGRAM

    May 1, 2020, 00:00
  • PBI14 TRASTUZUMAB BIOSIMILAR FOR BREAST CANCER TREATMENT IN BRAZILIAN PATIENTS: A BUDGET IMPACT ANALYSIS TO HELP DECISION MAKERS PROVIDE BETTER ACCESS

    May 1, 2020, 00:00
  • PMS13 HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH POLYMYALGIA RHEUMATICA IN THE UNITED STATES

    May 1, 2020, 00:00
  • PCV73 COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION AND PERCUTANEOUS CORONARY INTERVENTION: A NETWORK META-ANALYSIS WITH MULTICRITERIA DECISION ANALYSIS

    May 1, 2020, 00:00
  • Shedding Light on Reimbursement Policies of Companion Diagnostics in European Countries

    May 1, 2020, 00:00
  • PBI38 CHARACTERIZING THE USE OF CLINICAL OUTCOME ASSESSMENTS IN APPROVED GENE THERAPY TREATMENTS

    May 1, 2020, 00:00
  • PMH5 EFFICACY AND SAFETY OF LURASIDONE AND OTHER ATYPICAL ANTIPSYCHOTIC AGENTS FOR BIPOLAR DEPRESSION: UPDATED SYSTEMATIC REVIEW AND META-ANALYSES

    May 1, 2020, 00:00
  • PGI38 VOICING MY CHOICE: A QUALITATIVE EVALUATION OF PATIENTS' PERCEIVED USEFULNESS OF A PATIENT-CENTERED OPTION TOOL FOR COLORECTAL CANCER SCREENING IN AN INTERNAL MEDICINE CLINIC

    May 1, 2020, 00:00
  • PIH6 PREFERENCES AND WILLINGNESS TO PAY FOR EARLY DIAGNOSIS OF ENDOMETRIOSIS TO REDUCE THE ADVERSE RISK OUTCOMES: A DISCRETE CHOICE EXPERIMENT

    May 1, 2020, 00:00
  • PMS78 THE EFFECTS OF NEUROMUSCULAR TRAINING PROGRAM AMONG PROFESSIONAL ICE HOCKEY PLAYERS

    May 1, 2020, 00:00
  • PIN50 NON-SEXUAL RISK BEHAVIORS ARE ASSOCIATED WITH INCREASED ODDS OF HIV TESTING: RESULTS FROM THE 2017 BRFSS

    May 1, 2020, 00:00
  • Biologics/Biosimilars/Regenerative Medicine - Health Policy  Regulatory

    May 1, 2020, 00:00
  • PGI2 SYSTEMATIC REVIEW AND META-ANALYSIS OF INFLIXIMAB, ADALIMUMAB, GOLIMUMAB, VEDOLIZUMAB, AND TOFACITINIB FOR MODERATE-TO-SEVERE ULCERATIVE COLITIS IN ANTI-TNF-ALPHA-NAIVE PATIENTS

    May 1, 2020, 00:00
  • Medical Devices - Medical Technologies

    May 1, 2020, 00:00
  • Diabetes/Endocrine/Metabolic Disorders - Methodological Statistical Research

    May 1, 2020, 00:00
  • PMD6 INFECTIONS AND REOPERATIONS AFTER HAMMERTOE SURGERY IN OLDER PATIENTS

    May 1, 2020, 00:00
  • PIH46 COSTS AND OUTCOMES ASSOCIATED TO POTENTIALLY INAPPROPRIATE DRUG PRESCRIBING DETECTED BY ALGORITHM: PRELIMINARY RESULTS FROM THE MAPT STUDY

    May 1, 2020, 00:00
  • PDB108 CLINICAL INERTIA IN NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS AMONG PATIENTS ATTENDING SELECTED HEALTHCARE INSTITUTIONS IN COLOMBIA

    May 1, 2020, 00:00
  • PIH78 RASCH ANALYSIS OF THE STUDENT REFRACTIVE ERROR AND EYEGLASS QUESTIONNAIRE-R IN MYOPIC SCHOOL-AGED CHILDREN/CHILDREN AND YOUNG PEOPLE IN LONDON

    May 1, 2020, 00:00
  • PMS17 COST EFFECTIVENESS ANALYSIS OF UPADACITINIB AND METHOTREXATE FOR PATIENTS WITH METHOTREXATE-RESISTANT RHEUMATOID ARTHRITIS

    May 1, 2020, 00:00
  • PMD19 SYSTEMATIC LITERATURE REVIEW TO IDENTIFY THE CURRENT STATE OF KNOWLEDGE REGARDING HOME INFUSION VS MEDICAL-SETTING INFUSION

    May 1, 2020, 00:00
  • PIT9 BURDEN OF EMERGENCY DEPARTMENT VISIT AMONG ELDERLY DUE TO FALL

    May 1, 2020, 00:00
  • PMD41 ASSESSING THE CLINICAL EFFECTIVENESS OF POLYSOMNOGRAPHY AND PORTABLE DEVICE (LEVEL III) FOR THE DIAGNOSIS OF SLEEP DISORDER BREATHING: SYSTEMATIC REVIEW META-ANALYSIS

    May 1, 2020, 00:00
  • PIH14 COST-EFFECTIVENESS AND BUDGET IMPACT OF ADDING ETONORGESTREL CONTRACEPTIVE IMPLANT TO INDIA'S CURRENT FAMILY WELFARE PROGRAM

    May 1, 2020, 00:00
  • Drugs Generics - Economic Evaluation

    May 1, 2020, 00:00
  • PMS86 QUALITY OF LIFE AND WORK PRODUCTIVITY BY PAIN SEVERITY AMONG INDIVIDUALS WITH OSTEOARTHRITIS IN THE UNITED STATES: ANALYSIS OF A CROSS-SECTIONAL SURVEY

    May 1, 2020, 00:00
  • PDB105 STUDY OF INTERRUPTED TIME SERIES TO DETERMINE THE EFFECT OF POLICY IN PATIENTS WITH T2DM USING SGLT2 IN TWO HEALTH MAINTENANCE ORGANIZATION IN COLOMBIA

    May 1, 2020, 00:00
  • PMU22 A SYSTEMATIC REVIEW FOR BURDEN OF DISEASE STUDIES IN CHINA: ARE THERE STILL UNMET NEEDS?

    May 1, 2020, 00:00
  • PMS28 COST-UTILITY ANALYSIS OF TREATMENT OPTIONS AFTER INITIAL TUMOR NECROSIS FACTOR INHIBITOR THERAPY FAILURE IN PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2020, 00:00
  • PIH13 IMPACT OF INCREASED UTILIZATION OF LONG-ACTING REVERSABLE CONTRACEPTIVE METHODS AMONG YOUNG WOMEN ON COST AND UNINTENDED PREGNANCIES (UP) IN THE UNITED STATES (US)

    May 1, 2020, 00:00
  • PMH20 ECONOMIC BURDEN OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD): A GLOBAL SYSTEMATIC REVIEW

    May 1, 2020, 00:00
  • PIH2 EFFICACY AND SAFETY OF MIDAZOLAM ORAL SOLUTION FOR SEDATIVE-HYPNOSIS AND ANTI-ANXIETY IN CHILDREN: A SYSTEMATIC REVIEW AND META-ANALYSIS

    May 1, 2020, 00:00
  • PMU36 COST-UTILITY ANALYSIS OF SINGLE DOSE GENE-REPLACEMENT THERAPY FOR SPINAL MUSCULAR ATROPHY TYPE 1 COMPARED TO CHRONIC NUSINERSEN TREATMENT IN JAPAN

    May 1, 2020, 00:00
  • PMS26 ANNUAL HEALTH INSURANCE TREATMENT COST OF INJURIES TO THE KNEE AND LOWER LEG BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00
  • PDG11 COST MINIMIZATION ANALYSIS OF TRASTUZUMAB SUBCUTANEOUS VERSUS INTRAVENOUS IN TREATMENT OF HER2-POSITIVE EARLY OR METASTATIC BREAST CANCER IN VIETNAM

    May 1, 2020, 00:00
  • PMD40 FEMTOSECOND LASER ASSISTED CATARACT SURGERY: A REVIEW OF ITS EFFICIENCY COMPARED TO MANUAL CATARACT SURGERY

    May 1, 2020, 00:00
  • PDB43 QUALITY ADJUSTED LIFE YEARS (QALYS) IN THE DIABETES PREVENTION PROGRAM (DPP): QUALITY OF WELL BEING (QWB) VERSUS SF-6D INSTRUMENTS

    May 1, 2020, 00:00
  • PMH21 PROVIDING THE DEPRESSION CARE FOR PEOPLE WITH CANCER PROGRAM TO PROSTATE CANCER PATIENTS IN THE UNITED STATES: A COST-EFFECTIVENESS ANALYSES

    May 1, 2020, 00:00
  • PMH64 INPATIENT PRESCRIBING PATTERNS OF LONG-ACTING INJECTABLE ANTIPSYCHOTICS AND THEIR ORAL OR SHORT-ACTING INJECTABLE FORMULATIONS

    May 1, 2020, 00:00
  • PIH39 ASSOCIATION OF HEALTH-RELATED QUALITY OF LIFE AND PASSIVE SMOKE EXPOSURE IN PREGNANCY: EVIDENCE FROM A NATIONAL STUDY

    May 1, 2020, 00:00
  • Mental Health - Clinical Outcomes

    May 1, 2020, 00:00
  • PGI41 SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS OF HEALTH UTILITIES IN PATIENTS WITH ULCERATIVE COLITIS

    May 1, 2020, 00:00
  • PMS54 EPIDEMIOLOGICAL DISEASE BURDEN OF INJURIES TO THE SHOULDER AND UPPER ARM BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00
  • Cardiovascular Disorders - Health Service Delivery Process of Care

    May 1, 2020, 00:00
  • PIN3 RELATIVE VACCINE EFFECTIVENESS OF QUADRIVALENT CELL-BASED VERSUS EGG-BASED INFLUENZA VACCINES AMONG ADULTS 50-64 YEARS OLD: A U.S. OBSERVATIONAL COHORT STUDY

    May 1, 2020, 00:00
  • Musculoskeletal Disorders - Health Service Delivery Process of Care

    May 1, 2020, 00:00
  • PMS9 PLACEBO EFFECT IN KNEE OSTEOARTHRITIS: A TARGETED LITERATURE REVIEW ON THE CHALLENGES, HYPOTHESES, AND POTENTIAL SOLUTIONS

    May 1, 2020, 00:00
  • PDB29 A COST-UTILITY ANALYSIS OF SODIUM-GLUCOSE COTRANSPORTER (SGLT) 2 INHIBITORS IN ADDITION TO BASAL-BOLUS INSULIN IN THE TREATMENT OF TYPE 1 DIABETES IN THE USA USING THE PRIME DIABETES MODEL

    May 1, 2020, 00:00
  • PDB22 THE DIABETES PREVENTION PROGRAM (DPP) QUALITY OF WELL BEING (QWB) AND SF-6D UTILITY MEASURES AND MISSING DATA CONSIDERATIONS: AVAILABLE CASE ANALYSIS (ACA) VS. MANSKI LOWER AND UPPER BOUNDS (LMB AND UMB) RESULTS FOR UTILITIES AND QUAL ...

    May 1, 2020, 00:00
  • PDB27 THE DIABETES PREVENTION PROGRAM (DPP) QUALITY OF WELL BEING (QWB) UTILITY MEASURES AND MISSING DATA CONSIDERATIONS: AVAILABLE CASE ANALYSIS (ACA) VS. MANSKI LOWER AND UPPER BOUNDS (LMB AND UMB) RESULTS FOR UTILITIES AND QUALITY ADJUST ...

    May 1, 2020, 00:00
  • PDG39 CHALLENGE OR OPPORTUNITY? THE EXPANSION OF DRUG VOLUME-BASED PROCUREMENT IN CHINA

    May 1, 2020, 00:00
  • PDG27 OUTPATIENT CEPHALOSPORIN USE IN A COLOMBIAN POPULATION: PRESCRIPTION-INDICATION STUDY

    May 1, 2020, 00:00
  • PBI9 BUDGET IMPACT ANALYSIS OF OBINUTUZUMAB-CHEMOTHERAPY FOLLOWED BY OBINUTUZUMAB MAINTENANCE COMPARED TO RITUXIMAB-CHEMOTHERAPY FOLLOWED BY RITUXIMAB MAINTENANCE IN A CHILEAN HEALTH PUBLIC SYSTEM SETTING FOR NON-HODGKIN-LYMPHOMA PATIENTS

    May 1, 2020, 00:00
  • PCN11 REAL-WORLD TREATMENT PATTERNS IN RESECTABLE (STAGE I-IIIA) NON-SMALL CELL LUNG CANCER (NSCLC): A SYSTEMATIC LITERATURE REVIEW (SLR)

    May 1, 2020, 00:00
  • PIH55 TIME TRENDS AND FACTORS PREDICTING ANTICHOLINERGIC MEDICATION PRESCRIBING TO OLDER ADULTS IN THE UNITED STATES

    May 1, 2020, 00:00
  • PMS72 COMPUTERIZED ADAPTIVE TESTING OF ROUTINELY CAPTURED ORTHOPEDIC PRO MEASURES

    May 1, 2020, 00:00
  • PDG31 THE PRICING AND SPENDING TRENDS OF ULTRA-EXPENSIVE DRUGS IN MEDICARE PART D PROGRAM

    May 1, 2020, 00:00
  • PIH17 ECONOMIC IMPACT OF VAGUS NERVE STIMULATION THERAPY IN PEDIATRIC PATIENTS WITH DRUG-RESISTANT EPILEPSY

    May 1, 2020, 00:00
  • PBI43 REAL-WORLD EVIDENCE RECOMMENDATIONS FOR GENE THERAPIES: REGULATORY VERSUS HEALTH TECHNOLOGY ASSESSMENT

    May 1, 2020, 00:00
  • PCV61 EFFECTIVENESS OF A CARDIOVASCULAR RISK MANAGEMENT PROGRAM IN REDUCING THE PROBABILITY OF PREMATURE DEATH DUE TO CARDIOVASCULAR EVENTS IN THE COLOMBIAN CARIBBEAN REGION

    May 1, 2020, 00:00
  • PIH68 HEALTH-RELATED QUALITY OF LIFE MEASUREMENTS IN WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00
  • PMH25 CHARACTERISTICS AND HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER CONTINUING, SWITCHING, OR DISCONTINUING THERAPY IN A REAL-WORLD SETTING

    May 1, 2020, 00:00
  • PIN22 MORTALITY, MORBIDITY AND BURDEN OF HOSPITALIZATIONS IN INFLUENZA PATIENTS WITH LOW AND HIGH COMORBIDITY INDEX: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE

    May 1, 2020, 00:00
  • PCV83 COMPARISON OF TREATMENT ADHERENCE AND PERSISTENCE WITH EDOXABAN VERSUS APIXABAN, DABIGATRAN, RIVAROXABAN, AND VITAMIN K ANTAGONIST IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN GERMANY: A PROPENSITY MATCHED COHORT STUDY

    May 1, 2020, 00:00
  • Infectious Diseases - Health Technology Assessment

    May 1, 2020, 00:00
  • PDB51 IMPACT OF SENSOR AUGMENTED PUMP (SAP) IN TYPE 1 DIABETES MELLITUS (DMT1) PATIENTS IN COLOMBIA

    May 1, 2020, 00:00
  • PIH73 INFLUENCE OF MATERNAL MINDFULNESS TRAINING DURING PREGNANCY ON EXECUTIVE ABILITIES IN PRESCHOOL CHILDREN

    May 1, 2020, 00:00
  • PDB41 HOW MUCH DOES THERAPEUTIC INERTIA IN TYPE 2 DIABETES COST THE UK? A MODELING EVALUATION OF ECONOMIC BURDEN

    May 1, 2020, 00:00
  • PCV59 EPIDEMIOLOGICAL DISEASE BURDEN OF ACUTE MYOCARDIAL INFARCTION BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00
  • PMS74 THE EXAMINATION OF THE RELATIONSHIP BETWEEN BALANCE AND POSTURAL MUSCLES AMONG ELEMENTARY SCHOOL CHILDREN

    May 1, 2020, 00:00
  • Diabetes/Endocrine/Metabolic Disorders - Real World Data Information Systems

    May 1, 2020, 00:00
  • Individual's Health - Epidemiology Public Health

    May 1, 2020, 00:00
  • PDG16 A REVIEW OF THE EVIDENCE ON THE NET MONETARY BENEFIT OF SMOKING CESSATION INTERVENTIONS

    May 1, 2020, 00:00
  • Copyright/Subscription

    May 1, 2020, 00:00
  • PDB38 BURDEN OF CARDIOVASCULAR DISEASE AND CARDIOVASCULAR (CV) RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM): AN ANALYSIS OF A US HEALTH INSURANCE DATABASE

    May 1, 2020, 00:00
  • Medical Devices - Real World Data Information Systems

    May 1, 2020, 00:00
  • PIH9 BUDGET IMPACT ANALYSIS VS. COST EFFECTIVENESS ANALYSIS - HORMONAL CONTRACEPTIVES AS AN ILLUSTRATIVE CASE

    May 1, 2020, 00:00
  • PIH16 ESTIMATING THE VALUE OF NURSING TIME TO REDUCE COSTS AND INCREASE QUALITY OF PRESSURE INJURY PREVENTION IN NURSING HOMES: A COST-EFFECTIVENESS ANALYSIS OF THE TEAM-UP CLINICAL TRIAL

    May 1, 2020, 00:00
  • PIN44 SHORTENING TREATMENT FOR MULTIDRUG-RESISTANT TUBERCULOSIS IN BRAZIL: A COST-EFFECTIVENESS ANALYSIS

    May 1, 2020, 00:00
  • A Systematic Review of Economic Evaluations Reporting the Cost-Effectiveness of Spinal Cord Stimulation

    May 1, 2020, 00:00
  • PMU64 IS THERE AN ASSOCIATION BETWEEN NON-COMMUNICABLE DISEASE MORTALITY AND CORRUPTION INDEXES? A GLOBAL PERSPECTIVE

    May 1, 2020, 00:00
  • Musculoskeletal Disorders - Patient-Centered Research

    May 1, 2020, 00:00
  • PIT6 DISCRIMINATIVE ABILITY OF NEW INJURY SEVERITY SCORE TO PREDICT OUTCOMES AFTER FRACTURE REPAIRED SURGERY

    May 1, 2020, 00:00
  • PMU48 EFFECT OF MOBILE HEALTH INTERVENTIONS ON MATERNAL AND CHILD HEALTH: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS

    May 1, 2020, 00:00
  • PMU2 DEVELOPMENT AND USE OF SIMULATION-BASED TOOL INFORMING CLINICAL AND MARKET ACCESS STRATEGY

    May 1, 2020, 00:00
  • PIN64 INFLUENZA VACCINATION STATUS IN AMERICAN INDIANS AND ALASKA NATIVES FOR THE 2018‑2019 INFLUENZA SEASON IN TRINETX ELECTRONIC MEDICAL RECORD DATA

    May 1, 2020, 00:00
  • PDG61 TYPES OF ENDPOINTS OF NEW MOLECULAR ENTITIES APPROVED BY THE FDA: THE INCREASING IMPORTANCE OF PATIENT-REPORTED OUTCOMES

    May 1, 2020, 00:00
  • PCV54 AGE-SPECIFIC EXAMINATION OF EARLY CEREBROVASCULAR MORTALITY: 1990-2014

    May 1, 2020, 00:00
  • PBI41 LONGITUDINAL EVALUATION OF PRODUCT UTILIZATION AND CHARACTERISTICS AMONG PATIENTS TREATED WITH BIOLOGIC ANTI-INFLAMMATORY AGENTS: A STUDY BY THE BIOLOGICS AND BIOSIMILARS COLLECTIVE INTELLIGENCE CONSORTIUM

    May 1, 2020, 00:00
  • PMS87 PROGRESSIVE SUBAQUAL TRAINING 3 MONTHS FOLLOW-UP IN FALL PREVENTION OF OSTEOPOROTIC PATIENT

    May 1, 2020, 00:00
  • Injury Trauma - Clinical Outcomes

    May 1, 2020, 00:00
  • PBI26 RAPID REVIEW OF TRASTUZUMAB BIOSIMILARS COMPARED TO REFERENCE TRASTUZUMAB FOR BREAST CANCER TREATMENT IN NAIVE PATIENTS

    May 1, 2020, 00:00
  • PMH71 VALUE-BASED HEALTHCARE: CAN ARTIFICIAL INTELLIGENCE IMPROVE THE MENTAL HEALTH WITH BRAZILIAN DATA?

    May 1, 2020, 00:00
  • PDB56 CONTRASTING THREE TYPE 2 DIABETES CARDIOVASCULAR RISK EQUATIONS FOR EAST ASIA WITH UKPDS82 USING THE IQVIA CORE DIABETES MODEL

    May 1, 2020, 00:00
  • PMH32 PERCEPTION, PREVALENCE AND FACTORS ASSOCIATED TO SCHOOL BULLYING IN YOUNG PEOPLE FROM A POPULATION AFFILIATED IN A COLOMBIAN HEALTH SUBSIDIZED INSURANCE COMPANY IN 2018.

    May 1, 2020, 00:00
  • PIN24 INCIDENCE AND COSTS OF INFLUENZA-RELATED HOSPITALIZATIONS BY COMORBIDITY IN THE UNITED STATES

    May 1, 2020, 00:00
  • PDG71 DOES LIPID LOWERING THERAPY UP-TITRATION IN OLDER ADULTS IMPACT ADHERENCE?

    May 1, 2020, 00:00
  • PIN30 ESTIMATED BUDGET IMPACT OF THE INTRODUCTION OF DOLUTEGRAVIR/LAMIVUDINE (DTG/3TC) IN THE UNITED STATES FOR THE TREATMENT OF HIV INFECTION

    May 1, 2020, 00:00
  • PMS18 ANNUAL HEALTH INSURANCE TREATMENT COST OF INJURIES TO THE SHOULDER AND UPPER ARM BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00
  • Informing Patient-Centered Care Through Stakeholder Engagement and Highly Stratified Quantitative Benefit–Harm Assessments [Editor's Choice]

    May 1, 2020, 00:00
  • PDG18 DIFFERENCES IN RESOURCE UTILIZATION AND COSTS BETWEEN NARCOTIC USERS AND NON-NARCOTIC USERS FROM THE 2017 MEDICAL EXPENDITURE PANEL SURVEY

    May 1, 2020, 00:00
  • PDG25 UTILIZATION OF PRESCRIPTION OPIOIDS AND BENZODIAZEPINES AMONG ARKANSANS WITH MEDICAL CANNABIS IDENTIFICATION CARDS: A MATCHED CONTROL STUDY

    May 1, 2020, 00:00
  • Infectious Diseases - Clinical Outcomes

    May 1, 2020, 00:00
  • Alternative Medicine Nutrition - Patient-Centered Research

    May 1, 2020, 00:00
  • PCV66 GUIDELINE-DIRECTED MEDICAL THERAPY AMONG HEART FAILURE PATIENTS FACILITATED BY NATURAL LANGUAGE PROCESSING OF AMBULATORY ELECTRONIC HEALTH RECORDS

    May 1, 2020, 00:00
  • PMS46 USE OF HEALTHCARE RESOURCES IN A COHORT OF COLOMBIAN PATIENTS TREATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS OR TOFACITINIB, 2014–2018

    May 1, 2020, 00:00
  • PDB45 THE BUDGET IMPACT OF SITAGLIPTIN VERSUS ORAL SEMAGLUTIDE FROM A US PAYER PERSPECTIVE

    May 1, 2020, 00:00
  • PDB13 ASSOCIATION OF VERAPAMIL THERAPY AND REDUCED HYPOGLYCEMIC EVENTS AMONG MEDICARE PATIENTS WITH NEWLY DIAGNOSED TYPE 1 DIABETES

    May 1, 2020, 00:00
  • PMS36 THE ECONOMIC BURDEN OF FIBROMYALGIA IN CHINA

    May 1, 2020, 00:00
  • PMD14 PREVENTION VERSUS TREATMENT OF VENOUS ULCERS IN BRAZILIAN NATIONAL HEALTH SYSTEM: HOW MUCH COULD BE SAVED?

    May 1, 2020, 00:00
  • Biologics/Biosimilars/Regenerative Medicine - Epidemiology Public Health

    May 1, 2020, 00:00
  • Mental Health - Health Service Delivery Process of Care

    May 1, 2020, 00:00
  • Individual's Health - Health Service Delivery Process of Care

    May 1, 2020, 00:00
  • PGI7 EVALUATION OF LIVER OUTCOMES RELATIVE TO USE OF GLP-1 RECEPTOR AGONISTS (GLP1A) AND/OR SGLT-2 INHIBITORS (SGLT2I) IN REAL-WORLD POPULATIONS DIAGNOSED WITH TYPE II DIABETES (T2DM) AND NASH/NAFLD OR AT RISK OF NASH

    May 1, 2020, 00:00
  • PIN75 IMMUNIZATIONS AND INJECTABLE MEDICATIONS: PHARMACISTS' INTEREST, ENGAGEMENT, AND REIMBURSEMENT PATTERNS IN MISSISSIPPI

    May 1, 2020, 00:00
  • PIH3 ANGIOTENSIN I CONVERTING ENZYME INHIBITORS REDUCE RISK OF PNEUMONIA IN HOSPITALIZED ELDERLY PATIENTS

    May 1, 2020, 00:00
  • PMU23 QUANTIFYING THE COSTS OF OBESITY-RELATED COMPLICATIONS IN THE UNITED STATES: A RETROSPECTIVE DATABASE STUDY

    May 1, 2020, 00:00
  • PBI16 COST ANALYSIS OF TWO TREATMENTS BY INFLIXIMAB (ORIGINATOR AND BIOSIMILAR) FOR PATIENTS WITH RHUMATOÏD ARTHRITIS (RA) OR INFLAMMATORY BOWEL DISEASE (IBD) IN A GROUP OF FRENCH PUBLIC HOSPITALS (UNIHA)

    May 1, 2020, 00:00
  • PMH9 ESTIMATED COST-EFFECTIVENESS OF A 12-WEEK TREATMENT COURSE OF THE FIRST FDA-CLEARED PRESCRIPTION DIGITAL THERAPEUTIC FOR PATIENTS WITH OPIOID USE DISORDER

    May 1, 2020, 00:00
  • PIH23 A CLINICAL AND ECONOMIC ANALYSIS OF THE SINGLE-DOSE VERSUS MULTIPLE-DOSE APPROACHES OF SURFACTANT USE IN MECONIUM ASPIRATION SYNDROME IN NEONATAL INTENSIVE CARE UNITS IN QATAR

    May 1, 2020, 00:00
  • Mental Health - Epidemiology Public Health

    May 1, 2020, 00:00
  • PDB16 A POPULATION-ADJUSTED INDIRECT COMPARISON OF CARDIOVASCULAR BENEFITS BETWEEN ONCE-WEEKLY SEMAGLUTIDE AND DULAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES AND HIGH CARDIOVASCULAR RISK

    May 1, 2020, 00:00
  • PIN26 ECONOMIC IMPACT IN DOMINICAN REPUBLIC SENASA OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) VERSUS NO VACCINATION IN OLDER ADULTS

    May 1, 2020, 00:00
  • PDG4 DESCRIPTION OF PRESCRIPTION OPIOID USE AMONG US ADULTS

    May 1, 2020, 00:00
  • PMU4 EVIDENCE FOR THE USABILITY OF THE E-TSQM

    May 1, 2020, 00:00
  • Injury Statistical Research

    May 1, 2020, 00:00
  • PGI3 LEAN AND OBESE PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) / NON-ALCOHOLIC FATTY LIVER DISEASE (NALFD); COMPARISONS OF POPULATIONS AND DISEASE PROGRESSION

    May 1, 2020, 00:00
  • PCV72 DIFFERENTIAL USE OF TRANSCATHETER AORTIC VALVE IMPLANTS (TAVI). PERSONALIZATION STUDY

    May 1, 2020, 00:00
  • PMS2 RETROSPECTIVE ANALYSIS TO DETERMINE THE INCREASED RISK OF DEVELOPING OSTEOPOROSIS IN PATIENTS DIAGNOSED WITH DEPRESSION AND/OR PRESCRIBED ANTIDEPRESSANTS

    May 1, 2020, 00:00
  • Multiple Diseases - Economic Evaluation

    May 1, 2020, 00:00
  • PCV62 ASSOCIATED FACTORS TO THE CONTROL OF CARDIOVASCULAR RISK IN A LOW-INCOME POPULATION FROM THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00
  • PIN42 COMPARISON OF ECONOMIC BURDEN AND RISK OF HOSPITALIZATION AMONG HIV PATIENTS WITH AND WITHOUT HEPATITIS B COINFECTION IN THE VETERANS HEALTH ADMINISTRATION POPULATION

    May 1, 2020, 00:00
  • PDG35 EFFECT OF THE IMPLEMENTATION ON THE REGULATION OF DIRECT CONTROL OF MEDICINE’S PRICES IN COLOMBIA

    May 1, 2020, 00:00
  • Injury Trauma - Economic Evaluation

    May 1, 2020, 00:00
  • PMS33 BUDGET IMPACT ANALYSIS OF KNEE JOINT REPLACEMENT DELAY IN PATIENTS WITH SEVERE KNEE OSTEOARTHRITIS TREATED WITH HYLAN GF-20, LOW MOLECULAR WEIGHT HYALURONATES AND CORTICOSTEROIDS IN COLOMBIA

    May 1, 2020, 00:00
  • PMS76 ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS OF KNEE OSTEOARTHRITIS IN QUETTA, PAKISTAN

    May 1, 2020, 00:00
  • PMD4 THE IMPACT OF USING KNOTLESS SUTURE IN CARDIAC SURGERY ON DECREASING DEBRIDEMENT: A REAL WORLD STUDY IN A CHINESE TIER III HOSPITAL

    May 1, 2020, 00:00
  • PIN2 REAL-WORLD EFFECTIVENESS OF HEPATITIS C VIRUS (HCV) TREATMENT WITH DIRECT-ACTING ANTIVIRALS (DAA) IN POPULATIONS WITH FATTY LIVER/NON-ALCOHOLIC STEATOHEPATITIS (FL/NASH), DECOMPENSATED CIRRHOSIS (DCC), HEPATOCELLULAR CARCINOMA (HCC), A ...

    May 1, 2020, 00:00
  • PMS11 MEDICAL RESOURCE USE IN PATIENTS WITH PSORIATIC ARTHRITIS IN A COMPREHENSIVE RHEUMATOLOGICAL CENTER IN COLOMBIA

    May 1, 2020, 00:00
  • PIH75 ASSESSMENT OF THE RATIONALITY OF PRESCRIBING IN ELDERLY INPATIENTS OF A SOUTH INDIAN HOSPITAL USING BEERS 2015 AND STOPP CRITERIA

    May 1, 2020, 00:00
  • PDG43 STIMULANT AND NON-STIMULANT USE AMONG CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN US AMBULATORY VISITS

    May 1, 2020, 00:00
  • PGI22 ESTIMATING DIAGNOSTIC COSTS ASSOCIATED WITH A SECOND-GENERATION BLOOD TEST FOR ANTI-VINCULIN AND ANTI-CYTOLETHAL DISTENDING TOXIN B (CDTB) BIOMARKERS IN COMPARISON TO THE STANDARD EXCLUSIONARY APPROACH FOR IRRITABLE BOWEL SYNDROME WIT ...

    May 1, 2020, 00:00
  • PGI24 EPISODE OF CARE COSTS ASSOCIATED WITH MINIMALLY INVASIVE COLON SURGERY: A PROPENSITY-MATCHED ANALYSIS USING MEDICARE AND COMMERCIAL CLAIMS DATA

    May 1, 2020, 00:00
  • PMS22 ANNUAL HEALTH INSURANCE TREATMENT COST OF FEMORAL NECK FRACTURE BASED ON ROUTINELY COLLECTED, REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00
  • PCV52 EFFECTIVENESS OF A CARDIOVASCULAR DISEASE PREVENTION PROGRAM IN THE CONTROL OF CARDIOVASCULAR RISK FACTORS IN A LOW-INCOME POPULATION FROM THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00
  • Biologics/Biosimilars/Regenerative Medicine - Health Service Delivery Process of Care

    May 1, 2020, 00:00
  • PIH50 FACTORS AND PATTERNS OF OFF-LABEL PRESCRIBING IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN US. OUTPATIENT SETTINGS OVER A TEN-YEAR PERIOD

    May 1, 2020, 00:00
  • Mental Health - Health Policy Regulatory

    May 1, 2020, 00:00
  • PMS56 EPIDEMIOLOGICAL DISEASE BURDEN OF FRACTURE OF SKULL AND FACIAL BONES BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00
  • PMS23 RATE AND REIMBURSEMENT OF 1-LEVEL AND 2+-LEVEL REOPERATIONS IN CERVICAL TOTAL DISC REPLACEMENT AND ANTERIOR CERVICAL DISCECTOMY AND FUSION

    May 1, 2020, 00:00
  • PMH72 HEALTHCARE RESOURCE UTILIZATION (HRU) ASSOCIATED WITH EXTENDED-RELEASE NALTREXONE (XR-NTX) COMPARED WITH OTHER TREATMENTS IN PUBLICLY INSURED PATIENTS WITH OPIOID USE DISORDER (OUD)

    May 1, 2020, 00:00
  • PBI27 TRENDS IN AVERAGE SALES PRICES OF BIOLOGICS REIMBURSED BY THE MEDICARE PART B PROGRAM (FIRST QUARTER 2010-FIRST QUARTER 2020)

    May 1, 2020, 00:00
  • PMU27 ASSESSING RELATIONSHIPS AMONG HOSPITALIZATIONS FOR SPINE-RELATED INFECTIONS, DEMOGRAPHICS, COSTS, AND COMORBIDITY DIAGNOSES IN THE UNITED STATES

    May 1, 2020, 00:00
  • PMD20 ECONOMIC IMPACT OF SPECIALIZED LABORATORY AUTOMATION ON THE TURNAROUND TIME (TAT) MEAN AND STANDARD DEVIATION

    May 1, 2020, 00:00
  • PMH27 ADHD TREATMENT AND DIAGNOSIS AMONG TEENAGE AND COLLEGE-AGED WOMEN

    May 1, 2020, 00:00
  • PIN88 THE EXAMINATION OF THE PARENTAL DECISION ON CHOOSING VARICELLA VACCINATION

    May 1, 2020, 00:00
  • Alternative Medicine Process of Care

    May 1, 2020, 00:00
  • PDG45 LOW-VALUE CARE: THE ASSOCIATION OF ANTIPSYCHOTIC POLYPHARMACY USE TO ECONOMIC BURDEN IN NON-INSTITUTIONALIZED CIVILIAN POPULATION IN THE UNITED STATES

    May 1, 2020, 00:00
  • PMS67 DIFFERENCES IN HEALTHCARE EXPENDITURE BETWEEN OPIOID AND NON-OPIOID USERS AMONG A NATIONAL SAMPLE OF COMMUNITY-BASED OLDER UNITED STATES ADULTS WITH PAIN, 2015

    May 1, 2020, 00:00
  • PCV70 CLINICAL DECISION SUPPORT INTERVENTIONS FOR PROMOTING GUIDELINE-CONCORDANT ANTICOAGULATION IN PATIENTS WITH ATRIAL FIBRILLATION: TARGETED LITERATURE REVIEW OF KEY FEATURES AND GAPS IN EVIDENCE

    May 1, 2020, 00:00
  • PDB44 DOES INCLUDING ACUTE PANCREATITIS AS A COMPLICATION HAVE AN IMPACT ON COST-EFFECTIVENESS ANALYSES USING THE IQVIA CORE DIABETES MODEL?

    May 1, 2020, 00:00
  • Individual's Health - Health Policy Regulatory

    May 1, 2020, 00:00
  • PDB64 THERAPEUTIC INERTIA IN THE TREAMENT OF PATIENTS WITH TYPE 2 DIABETES IN A CARDIOVASCULAR RISK MANAGEMENT COHORT FROM THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00
  • PMD3 ONE-YEAR COMPLICATIONS AND REIMBURSEMENT AFTER FIXATION WITH PLATING AND SCREWS FOR DISTAL FEMUR FRACTURES AMONG THE MEDICARE POPULATION

    May 1, 2020, 00:00
  • Medical Devices - Methodological Statistical Research

    May 1, 2020, 00:00
  • PDG66 QUALITY OF LIFE AND ADHERENCE OF PATIENTS TO ORAL NEUROLOGY SPECIALTY MEDICATIONS PROVIDED BY A SPECIALTY PHARMACY

    May 1, 2020, 00:00
  • PGI11 COMPARISON OF BURDEN OF HOSPITALIZATIONS IN INFLAMMATORY BOWEL DISEASE (IBD) WITH AND WITHOUT COLORECTAL CANCER: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE

    May 1, 2020, 00:00
  • PDB20 IS HYPOGLYCEMIA EXPENSIVE?

    May 1, 2020, 00:00
  • Musculoskeletal Disorders - Medical Technologies

    May 1, 2020, 00:00
  • PMS94 PREDICTORS OF IMPROVEMENT IN TENDER JOINT COUNTS AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN A LARGE, REPRESENTATIVE US-BASED REAL WORLD REGISTRY COHORT

    May 1, 2020, 00:00
  • PIH64 ADJUSTED INDIRECT COMPARISON OF THE MEDICINES USING IN CONTROLLED OVARIAN STIMULATION FOR ASSISTED REPRODUCTIVE TECHNOLOGY

    May 1, 2020, 00:00
  • PMS16 ANNUAL HEALTH INSURANCE TREATMENT COST OF SCOLIOSIS BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00
  • PIH25 PRE-TERM LABOR TRANSPORT: UTILIZATION PATTERNS AND COST AMONG WOMEN IN RURAL AND NON-RURAL AREAS

    May 1, 2020, 00:00
  • PCV67 OPERATIONAL FEASIBILITY OF PHARMACIST GUIDED PERSONALIZED CONSULT SERVICE IN MANDATORY AND OPTIONAL SETTINGS

    May 1, 2020, 00:00
  • PMH28 ANTIPSYCHOTIC DRUG USE AMONG A US NATIONAL COHORT OF OLDER DEMENTIA PATIENTS USING ACETYLCHOLINESTERASE INHIBITORS

    May 1, 2020, 00:00
  • Defining Comparators According to IQWiG’s Efficiency-Frontier Method

    May 1, 2020, 00:00
  • PIN72 NON-PRESCRIPTION SALES OF ANTIMICROBIALS FROM COMMUNITY PHARMACIES AND DETERMINANTS OF RESISTANCE IN LAHORE PAKISTAN

    May 1, 2020, 00:00
  • PIN54 MODELLING THE EFFECT OF TARGETED TREATMENT IN A TB OUTBREAK WITH COMPLEX CONTAGION

    May 1, 2020, 00:00
  • Medical Devices - Economic Evaluation

    May 1, 2020, 00:00
  • PMS89 A REAL-WORLD STUDY OF THE PATIENT EXPERIENCE WITH ABALOPARATIDE

    May 1, 2020, 00:00
  • PDG13 CURRENT PRESCRIPTION PROFILE OF RIBAVIRIN FOR HEPATITIS C IN BRAZIL AND THE BUDGET IMPACT ANALYSIS ON UPDATED RECOMMENDATIONS FOR ITS USE BETWEEN 2020 AND 2024 IN THE BRAZILIAN PUBLIC HEALTH SYSTEM

    May 1, 2020, 00:00
  • Individual's Health - Economic Evaluation

    May 1, 2020, 00:00
  • PMH66 THE BURDEN OF COST TO PATIENTS WITH OPIOID USE DISORDER TREATED WITH MEDICATION ASSISTED THERAPY: A SYSTEMATIC SCOPING REVIEW

    May 1, 2020, 00:00
  • PGI13 A BUDGET IMPACT ANALYSIS OF FIDAXOMICIN FOR THE MANAGEMENT OF CLOSTRIDIOIDES DIFFICILE INFECTION IN THE UNITED STATES

    May 1, 2020, 00:00
  • PCN16 RESECTION FOR RECURRENT BRAIN METASTASES: A SYSTEMATIC REVIEW AND META-ANALYSIS

    May 1, 2020, 00:00
  • PMS83 PILOT INVESTIGATION OF THE QUALITY OF LIFE AND SOCIO-DEMOGRAPHIC FACTORS OF PATIENTS UNDERWENT TOTAL HIP ARTHROPLASTY IN THE STATE HEALTH CARE SECTOR IN HUNGARY

    May 1, 2020, 00:00
  • PBI7 BUDGET IMPACT ANALYSIS OF INTRODUCTION OF BEVACIZUMAB BIOSIMILAR IN THE UNITED STATES FROM A PAYER PERSPECTIVE

    May 1, 2020, 00:00
  • PDG24 OPIOID-RELATED OVERDOSE IN PATIENTS WITH CONCURRENT USE OF OPIOIDS AND BENZODIAZEPINES: A NESTED CASE-CONTROL STUDY OF COMMERCIALLY INSURED PATIENTS

    May 1, 2020, 00:00
  • Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019

    May 1, 2020, 00:00
  • Medical Devices - Health Technology Assessment

    May 1, 2020, 00:00
  • PDB48 THE COMPARISON OF SGLT2 INHIBITORS AND DPP-4 INHIBITORS ON HEALTH CARE EXPENDITURE AND UTILIZATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

    May 1, 2020, 00:00
  • PMS79 PHASE 1B EVALUATION OF PATIENT EXPERIENCE WITH ABALOPARATIDE SOLID MICROSTRUCTURED TRANSDERMAL SYSTEM IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY

    May 1, 2020, 00:00
  • Cancer - Clinical Outcomes

    May 1, 2020, 00:00
  • PMD31 IS A SUPERFICIAL INFECTION AN INDEPENDENT PREDICTOR FOR A LATER DEEP INCISIONAL INFECTION IN TOTAL KNEE ARTHROPLASTY?

    May 1, 2020, 00:00
  • PIH40 INCIDENCE AND BURDEN OF RECURRENT VAGINITIS AMONG COMMERCIALLY INSURED WOMEN IN THE US

    May 1, 2020, 00:00
  • Comparative Effectiveness Studies Methods

    May 1, 2020, 00:00
  • PMS81 PRESCRIPTION DRUG COVERAGE TYPE, OUT-OF-POCKET SPENDING, AND COST-RELATED NONADHERENCE AMONG MEDICARE BENEFICIARIES WITH RHEUMATOID ARTHRITIS

    May 1, 2020, 00:00
  • PDG67 PREDICTORS OF CHRONIC MEDICATION NONADHERENCE IN CANCER SURVIVORS: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00
  • PMS4 OUTPATIENT COSTS IN RHEUMATOID ARTHRITIS (RA) PATIENTS WITH VS WITHOUT COMORBIDITIES

    May 1, 2020, 00:00
  • PMH51 WHAT ARE THE ATTRIBUTES THAT PSYCHIATRISTS CONSIDER IN THE DECISION TO DISCHARGE ADULTS WITH MAJOR DEPRESSIVE DISORDER WHO HAVE BEEN HOSPITALIZED WITH ACTIVE SUICIDAL IDEATION WITH INTENT?

    May 1, 2020, 00:00
  • PDB21 EVALUATION OF THE ONE-YEAR EFFICIENCY OF THE EDUC@DOM TELEMONITORING AND TELE-EDUCATION PROGRAM FOR TYPE 2 DIABETIC PATIENTS

    May 1, 2020, 00:00
  • PBI34 IMPACTS OF LONG-TERM UNCERTAINTY AND FAMILY SPILLOVER EFFECTS ON THE COST-UTILITY OF APPROVED TREATMENTS FOR SMA TYPE I

    May 1, 2020, 00:00
  • PMH37 FACTORS INFLUENCING THE UPTAKE OF MENTAL HEALTH SERVICES IN SUB-SAHARAN AFRICA.

    May 1, 2020, 00:00
  • PGI17 COST EFFECTIVENESS ANALYSIS OF ENDOSCOPIC CAPSULE FOR DIAGNOSIS OF OBSCURE GASTROINTESTINAL BLEEDING IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    May 1, 2020, 00:00
  • PIN55 ASSOCIATION OF GEOGRAPHIC FACTORS AND SOCIAL DETERMINANTS WITH HERPES ZOSTER VACCINATION

    May 1, 2020, 00:00
  • Alternative Medicine Nutrition - Clinical Outcomes

    May 1, 2020, 00:00
  • PMU32 A DEVICE CATEGORY-BASED ECONOMIC MODEL EXPLORING ELECTROSURGERY TECHNOLOGIES ACROSS PROCEDURE TYPES: A CHINESE ANALYSIS

    May 1, 2020, 00:00
  • PCV87 HEART FAILURE RISK FACTORS ANALYSIS ON STABLE CORONARY ARTERY DISEASE PATIENTS IN CHINA

    May 1, 2020, 00:00
  • Mental Health - Health Technology Assessment

    May 1, 2020, 00:00
  • Musculoskeletal Disorders - Epidemiology Public Health

    May 1, 2020, 00:00
  • PCV79 GENDER DISPARITY IN THE INITIATION AND COMPLIANCE FOR STATIN THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE (CAD)

    May 1, 2020, 00:00
  • PMS12 HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH GIANT CELL ARTERITIS IN THE UNITED STATES

    May 1, 2020, 00:00
  • PIH76 ITCH REPORTED OUTCOME TOOL FOR CAREGIVERS OF PEDIATRIC PATIENTS WITH CHOLESTATIC LIVER DISEASE: AN ANALYSIS OF VALIDATION AND SCORING FROM THE ICONIC MARALIXIBAT STUDY

    May 1, 2020, 00:00
  • PCN7 COMPARATIVE EFFECTIVENESS OF GRANULOCYTE COLONY STIMULATING FACTOR UTILIZATION VERSUS CHEMOTHERAPY DOSE REDUCTION ON OVERALL SURVIVAL: A PROPENSITY SCORE MATCHED ANALYSIS

    May 1, 2020, 00:00
  • PB3 DISCORDANCE BETWEEN PSYCHIATRISTS AND THEIR PATIENTS ON DISEASE SEVERITY AND TREATMENT OUTCOMES IN SCHIZOPHRENIA

    May 1, 2020, 00:00
  • PDG38 ASSESSMENT OF GENERIC COMPETITION FOR ORPHAN DRUGS MARKETED IN THE US (1993-2019)

    May 1, 2020, 00:00
  • PDB28 QUALITY ADJUSTED LIFE YEARS (QALYS) IN THE DIABETES PREVENTION PROGRAM (DPP) USING QUALITY OF WELL BEING (QWB) AND SF-6D INSTRUMENTS IN SAME SAMPLE: COMPLETE CASE ANALYSIS

    May 1, 2020, 00:00
  • PGI30 WEB-BASED RESEARCH OF QUALITY OF LIFE OUTCOME AND STATUS OF MEDICAL EXPENSE SUBSIDY FOR INTRACTABLE DISEASE FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN JAPAN

    May 1, 2020, 00:00
  • Multiple Diseases - Clinical Outcomes

    May 1, 2020, 00:00
  • PDB57 VALIDATION OF UKPDS OUTCOMES AND TAIWAN DIABETES MODELS ON TAIWAN TYPE 2 DM POPULATION

    May 1, 2020, 00:00
  • PMD23 ANALYSIS OF THE COST-EFFECTIVENESS OF TRANSCATHETER AORTIC VALVE REPLACEMENT AS ALTERNATIVE TO SURGICAL AORTIC VALVE REPLACEMENT IN PRIVATE HEALTH INSURANCE IN BRAZIL

    May 1, 2020, 00:00
  • PIH18 POLYPHARMACY, HEALTHCARE EXPENDITURES AND HEALTH STATUS AMONG OLDER ADULTS WITH CARDIAC DISEASE

    May 1, 2020, 00:00
  • PMD17 ANALYSIS OF THE COST-EFFECTIVENESS OF ENDOVASCULAR AORTIC REPAIR WITH OFF-THE-SHELF ENDOGRAFTS AS ALTERNATIVE TO CUSTOM-MADE ENDOGRAFTS IN PRIVATE HEALTH INSURANCE IN BRAZIL

    May 1, 2020, 00:00
  • Biologics/Biosimilars/Regenerative Medicine - Clinical Outcomes

    May 1, 2020, 00:00
  • PIN62 PREVALENCE AND FACTORS ASSOCIATED WITH NEVER-VACCINATED CHILDREN AGED 12-59 MONTHS IN ETHIOPIA. A MULTILEVEL ANALYSIS OF THE INDIVIDUAL AND CONTEXTUAL FACTORS

    May 1, 2020, 00:00
  • PBI35 HEALTH TECHNOLOGY ASSESSMENT (HTA) REVIEW OF CELL GENE THERAPIES: THE ROAD TO REIMBURSEMENT

    May 1, 2020, 00:00
  • PBI20 COMPARISON OF DECISION MODELING APPROACHES FOR HEALTH TECHNOLOGY AND POLICY EVALUATION

    May 1, 2020, 00:00
  • PMU41 PREVALENCE AND ASSOCIATED FACTORS TO SUICIDE ATTEMPTS IN LOW-INCOME ADOLESCENTS FROM THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00
  • PIH48 DIFFERENTIAL PRESCRIPTION PATTERNS OF DROSPIRENONE-CONTAINING COMBINED ORAL CONTRACEPTIVES IN EUROPE AND NORTH AMERICA - INSIGHTS FROM THE INAS-FOCUS STUDY

    May 1, 2020, 00:00
  • PMD25 EVALUATING BUDGET IMPACT OF PERIPROSTHETIC JOINT INFECTION DIAGNOSIS PATHWAYS IN TOTAL HIP AND KNEE ARTHROPLASTY PATIENTS

    May 1, 2020, 00:00
  • PMS3 LORECEVIVINT, A POTENTIAL DISEASE-MODIFYING TREATMENT FOR KNEE OSTEOARTHRITIS: FACTORS DRIVING WOMAC PAIN SUBSCORE CHANGES - A POST HOC ANALYSIS OF PHASE 2B DATA

    May 1, 2020, 00:00
  • PCN13 FACTORS THAT MODIFY THE EFFECT OF MONO- OR COMBINATION PD-1/PD-L1 INHIBITOR THERAPIES ON SURVIVAL OUTCOMES IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS

    May 1, 2020, 00:00
  • PIN9 ADHERENCE ISSUES AMONG PEOPLE LIVING WITH HIV ON ANTIRETROVIRAL THERAPY AND CONCOMITANT NON-ANTIRETROVIRAL COMEDICATIONS: A SYSTEMATIC REVIEW

    May 1, 2020, 00:00
  • PMU14 THE USE OF PERSPECTIVE AND COSTING APPROACHES IN COST-EFFECTIVENESS ANALYSIS

    May 1, 2020, 00:00
  • PIH82 PREVALENCE AND PREDICTORS OF POLYPHARMACY AND POTENTIALLY INAPPROPRIATE MEDICATIONS IN A LARGE COMMUNITY-DWELLING OLDER POPULATION IN ITALY

    May 1, 2020, 00:00
  • Musculoskeletal Disorders - Health Policy Regulatory

    May 1, 2020, 00:00
  • PIN89 REGIMEN DURABILITY AMONG HEAVILY TREATMENT-EXPERIENCED (HTE) COMPARED TO NON-HTE TREATMENT-EXPERIENCED HIV PATIENTS IN THE OPERA COHORT

    May 1, 2020, 00:00
  • PIN38 COST-EFFECTIVENESS OF TESAMORELIN IN THE TREATMENT OF LIPOHYPERTROPHY IN THE US

    May 1, 2020, 00:00
  • PIN73 KNOWLEDGE OF TUBERCULOSIS AMONG PATENT AND PROPRIETARY MEDICINE VENDORS IN RURAL AREAS OF ENUGU STATE IN SOUTHEAST NIGERIA

    May 1, 2020, 00:00
  • Cost-Effectiveness Studies

    May 1, 2020, 00:00
  • PGI4 RETROSPECTIVE STUDY OF DOSE ESCALATION WITH ADALIMUMAB, INFLIXIMAB, AND VEDOLIZUMAB IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

    May 1, 2020, 00:00
  • PDG52 CONCOMITANT USE OF OPIOIDS AND CENTRAL NERVOUS SYSTEM DEPRESSANTS IN PATIENTS WITH NONMALIGNANT CHRONIC PAIN AND ADHERENCE TO FOOD AND DRUG ADMINISTRATION WARNING

    May 1, 2020, 00:00
  • PMS34 TALTZ® (IXEKIZUMAB) FOR TREATMENT OF PSORIATIC ARTHRITIS IN THE UNITED STATES: A BUDGET IMPACT ANALYSIS

    May 1, 2020, 00:00
  • PDB40 COST-EFFECTIVENESS ANALYSIS OF SENSOR-AUGMENTED PUMP IN TYPE 1 DIABETES MELLITUS COMPARED WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN THE RUSSIAN FEDERATION

    May 1, 2020, 00:00
  • PMU46 PSYCHOTROPIC POLYPHARMACY AMONG CHILDREN, ADOLESCENTS, AND YOUNG ADULTS TREATED WITH ANTIDEPRESSANTS IN THE UNITED STATES

    May 1, 2020, 00:00
  • PDB39 COST-EFFECTIVENESS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN ARGENTINA

    May 1, 2020, 00:00
  • PDG26 THE ASSOCIATION OF BETA-BLOCKERS USE TO CHRONIC PAIN AMONG ADULTS WITH CARDIOVASCULAR DISEASES (CVD) OR HYPERTENSION IN THE UNITED STATES

    May 1, 2020, 00:00
  • PIH15 ANNUAL HEALTH INSURANCE TREATMENT COST OF ENDOMETRIOSIS BASED ON ROUTINELY COLLECTED FINANCING DATA

    May 1, 2020, 00:00
  • PIN12 THE COST-EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN CHINESE CITIES

    May 1, 2020, 00:00
  • PDB54 EVALUATING THE IMPACT OF POOR GLYCEMIC CONTROL ASSOCIATED WITH THERAPEUTIC INERTIA ON LIFE EXPECTANCY IN PATIENTS WITH TYPE 2 DIABETES IN THE UK

    May 1, 2020, 00:00
  • PIH67 EVALUATING THE BURDEN OF ILLNESS OF PEDIATRIC PLATINUM-INDUCED HEARING LOSS: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00
  • PIN59 17-YEAR DISEASE REDUCTION PREDICTED BY A TRANSMISSION DYNAMIC MODEL AFTER PNEUMOCOCCAL CONJUGATE VACCINE INTRODUCTION IN THE UNITED STATES

    May 1, 2020, 00:00
  • PMH17 ECONOMIC BURDEN OF MEDICAID BENEFICIARIES WITH SCHIZOPHRENIA NOT ADHERENT TO ANTIPSYCHOTICS AND WITH SCHIZOPHRENIA RELAPSES

    May 1, 2020, 00:00
  • PDB10 EVALUATION OF THE RATE OF PREVENTABLE DIABETES-RELATED HOSPITALIZATIONS IN MEDICAID

    May 1, 2020, 00:00
  • PDG17 COST-EFFECTIVENESS ANALYSIS OF ARSENIC TRIOXYDE FOR FIRST LINE TREATMENT OF ACUTE PROMYELOCTIC LEUKEMIA

    May 1, 2020, 00:00
  • PDG44 COPRESCRIBING OF OPIOIDS AND BENZODIAZEPINES IN TEXAS MEDICAID ENROLLEES

    May 1, 2020, 00:00
  • PMD46 RETROSPECTIVE ANALYSIS OF OXIDIZED ZIRCONIUM BEARING SURFACE AND MORTALITY IN HIP AND KNEE REPLACEMENT 180-DAY EPISODE CLAIMS

    May 1, 2020, 00:00
  • PBI3 TRANSFUSION-RELATED ABO INCOMPATIBILITY REACTIONS AMONG THE INPATIENT U.S. MEDICARE BENEFICIARIES, AGES 65 AND OLDER, DURING 2007-2018

    May 1, 2020, 00:00
  • Alternative Medicine Information Systems

    May 1, 2020, 00:00
  • PMS45 CLINICAL CHARACTERISTICS AND HEALTH OUTCOMES IN A GROUP OF ELDERLY PATIENTS WITH HIP FRACTURE IN MANIZALES, COLOMBIA.

    May 1, 2020, 00:00
  • PMS20 COST EFFECTIVENESS OF VIRTUAL REALITY GAME VERSUS CLINIC BASED MCKENZIE EXTENSION THERAPY FOR CHRONIC NON SPECIFIC LOW BACK PAIN

    May 1, 2020, 00:00
  • PMS42 HEALTHCARE EXPENDITURE HEALTH-RELATED QUALITY OF LIFE OF MUSCULOSKELETAL PAIN PATIENTS ON OPIOIDS VERSUS NSAIDS

    May 1, 2020, 00:00
  • PDG9 PREVALENCE OF POLYMEDICATION IN POOR POPULATION OF THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00
  • PMD10 A BUDGET IMPACT AND RETURN ON INVESTMENT ANALYSIS OF INCORPORATING DRUG – ELUTING STENTS INTO A CHINESE HOSPITAL MEDICAL DEVICE FORMULARY — A HOSPITAL PERSPECTIVE

    May 1, 2020, 00:00
  • PIH38 MEASURING A RISK OF AND FACTORS ASSOCIATED WITH IN-HOME TOBACCO SMOKE EXPOSURE IN A US PEDIATRIC SAMPLE: HOUSEHOLD ECONOMICS AND VOLATILE ORGANIC COMPOUND METABOLITE DETECTION

    May 1, 2020, 00:00
  • PCV88 THE APPLICATION OF BAYESIAN HETEROGENEITY TREATMENT EFFECT ANALYSIS FOR ASSESSING VARIATION AND RELIABILITY OF CONGESTIVE HEART FAILURE OUTCOMES IN A LINKED EMR-CLAIMS DATASET

    May 1, 2020, 00:00
  • PMU19 FIRST LINE TREATMENT WITH NATALIZUMAB REDUCES HEALTHCARE RESOURCE USE AND IMPAIRMENT OF WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENTS COMPARED TO NATALIZUMAB DELAYED USE

    May 1, 2020, 00:00
  • PMU5 PREVALENCE AND ASSOCIATED FACTORS TO PSYCHOTIC SUBSTANCE USE IN LOW-INCOME ADOLESCENTS FROM THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00
  • PGI26 THE COST-EFFECTIVENESS OF PHARMACOLOGIC VS SURGICAL INTERVENTION FOR PATIENTS HOSPITALIZED WITH ACUTE SEVERE ULCERATIVE COLITIS IN THE UNITED STATES

    May 1, 2020, 00:00
  • PAM2 ORAL NUTRITIONAL SUPPLEMENTATION CAN IMPROVE POSTOPERATIVE OUTCOMES FOR COLORECTAL SURGERY PATIENTS

    May 1, 2020, 00:00
  • PGI20 THE IMPACT OF ULCERATIVE COLITIS ON WORK PRODUCTIVITY: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00
  • Mental Health - Real World Data Information Systems

    May 1, 2020, 00:00
  • PMU44 PREVALENCE OF MULTIMORBIDITY AMONG ASIAN INDIANS, CHINESE, AND NON-HISPANIC WHITES IN THE UNITED STATES

    May 1, 2020, 00:00
  • PCV65 HOSPITALIZATIONS AND MORTALITY AMONG CARDIAC AMYLOIDOSIS PATIENTS COVERED BY MEDICARE ADVANTAGE

    May 1, 2020, 00:00
  • PDB23 EXLORATION IN HEALTHCARE RESOURCE UTILIZATION (HCRU) STUDY USING EMR DATABASE AND CLAIMS DATA

    May 1, 2020, 00:00
  • PCN14 UPDATED NETWORK META-ANALYSIS OF FIRST-LINE EGFR-TARGETED TYROSINE KINASE INHIBITOR TREATMENTS FOR LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER WITH EGFR-ACTIVATING MUTATIONS

    May 1, 2020, 00:00
  • PGI35 REAL-WORLD MEDICATION USE AND COST OF ILLNESS IN IRRITABLE BOWEL SYNDROME WITH CONSTIPATION IN THE CHINESE SETTING

    May 1, 2020, 00:00
  • PDB83 THE ROLE OF HEALTH CARE PROVIDER'S ADVICE IN PREDIABETES MANAGEMENT IN THE US

    May 1, 2020, 00:00
  • PDG6 HEALTH JUDICIALIZATION IN BRAZIL: IMPACT OF MIGLUSTATE MEDICINE OBLIGATION FOR PATIENTS WITHOUT OFFICIAL INDICATION OF USE, IN 2019 IN BRAZIL

    May 1, 2020, 00:00
  • PDG33 CHANGES IN SCHEDULE II ORAL OPIOID VOLUME DISPENSED IN A PRIVATE PAYER FOLLOWING FLORIDA’S ACUTE PAIN OPIOID RESTRICTION LAW

    May 1, 2020, 00:00
  • PIN69 NOW OR LATER: THE COST BURDEN OF HCV INFECTION VS. TREATMENT FOR MEDICARE AND MEDICAID POPULATIONS

    May 1, 2020, 00:00
  • PMS30 ANNUAL HEALTH INSURANCE TREATMENT COST OF SUBTROCHANTERIC FRACTURE BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00
  • PIN4 IMPACT OF ADHERENCE ON VIRAL SUPPRESSION IN PATIENTS WITH HIV RECEIVING BICTEGRAVIR OR DOLUTEGRAVIR REGIMENS

    May 1, 2020, 00:00
  • Alternative Medicine Statistical Research

    May 1, 2020, 00:00
  • PMU6 EFFECTIVENESS OF A NATIVE TYPE I COLLAGEN MATRIX PLUS POLYHEXAMETHYLENE BIGUANIDE ANTIMICROBIAL (PHMB) FOR THE TREATMENT OF CUTANEOUS WOUNDS IN A REAL WORLD SETTING

    May 1, 2020, 00:00
  • PMU15 RETROSPECTIVE STUDY EXAMINING HEALTH CARE UTILIZATION AND COSTS FOR PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS IN THE US

    May 1, 2020, 00:00
  • PMU33 THE IMPACT OF HIGH RISK AND CHRONIC OPOID USE AMONG COMMERCIALLY INSURED ENDOMETRIOSIS PATIENTS ON HEALTHCARE RESOURCE USE AND COSTS IN THE UNITED STATES

    May 1, 2020, 00:00
  • PCV86 EXAMINING PREDICTORS OF DURATION OF INITIAL ANTIHYPERTENSIVE THERAPY

    May 1, 2020, 00:00
  • Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing–Based Tests: Challenges, Opportunities, and Potential Solutions

    May 1, 2020, 00:00
  • PBI42 DISCONTINUATION PLAYS A ROLE WHEN EVALUATING THE COST EFFECTIVENESS OF THE SECOND BIOLOGICAL DRUG FOR PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2020, 00:00
  • PCV89 ASSESSMENT OF CARE OPPORTUNITY GAPS FOR ATRIAL FIBRILLATION IN NHS ENGLAND

    May 1, 2020, 00:00
  • PMS19 A SYSTEMATIC REVIEW OF ECONOMIC MODELS FOR COST EFFECTIVENESS OF PHYSIOTHERAPY INTERVENTION FOLLOWING TOTAL KNEE AND HIP REPLACEMENT

    May 1, 2020, 00:00
  • PIN21 ESTABLISH A PHARMACEUTICAL CARE MODE FOR THERAPEUTIC DRUG MONITORING OF VANCOMYCIN AND EVALUATE ITS EFFECTIVENESS AND ECONOMICS

    May 1, 2020, 00:00
  • Cardiovascular Disorders - Health Technology Assessment

    May 1, 2020, 00:00
  • PDB92 GETTING THE MOST OUT OF LATENT-CLASS ANALYSIS IN MODELING PREFERENCES FOR AN INTERCEPTION TREATMENT IN TYPE 1 DIABETES

    May 1, 2020, 00:00
  • PDG32 GAME-THEORETICAL ANALYSIS OF NETFLIX PAYMENT MODEL FOR HEPATITIS C TREATMENT

    May 1, 2020, 00:00
  • PIH70 FORMATIVE RESEARCH TO DEVELOP A CLINICAL TRIAL DECISION AID THAT INTEGRATES QUANTITATIVE PATIENT PREFERENCE DATA

    May 1, 2020, 00:00
  • PDB111 A COMPARATIVE EFFECTIVENESS RESEARCH STUDY OF A NATIVE TYPE I COLLAGEN MATRIX PLUS POLYHEXAMETHYLENE BIGUANIDE ANTIMICROBIAL AND A CRYOPRESERVED CADAVERIC SKIN ALLOGRAFT FOR USE IN DIABETIC FOOT ULCERS - A NON-INFERIORITY ANALYSIS

    May 1, 2020, 00:00
  • PBI23 DEPRESSION AND OBESITY DIFFERENCES AMONG PSORIASIS PATIENTS BY BIOLOGICS TREATMENT

    May 1, 2020, 00:00
  • PIN6 CLINICAL BENEFITS AND COST SAVINGS FROM IMPLEMENTING A SIMPLIFIED STRATEGY FOR GLECAPREVIR/PIBRENTASVIR (G/P) 8-WEEK TREATMENT IN NON-CIRRHOTIC NAÃVE PATIENTS WITH HEPATITIS C. THE JUST SIMPLE STUDY (REAL CLINICAL PRACTICE IN SPAIN).

    May 1, 2020, 00:00
  • PDB50 ANNUAL HEALTH INSURANCE TREATMENT COST OF DIABETIC POLYNEUROPATHY BASED ON ROUTINELY COLLECTED FINANCING DATA

    May 1, 2020, 00:00
  • Injury Public Health

    May 1, 2020, 00:00
  • PMH15 THE CHANGES OF DEPRESSION COSTS AFTER AN INTERNET-DELIVERED COGNITIVE BEHAVIOUR THERAPIES (IDCBT) PRELIMINARY DATA FROM RWD ECONOMIC MODEL

    May 1, 2020, 00:00
  • PMS55 EPIDEMIOLOGICAL DISEASE BURDEN OF INJURIES TO THE KNEE AND LOWER LEG BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00
  • PMH11 LONG-TERM MEDICATION-ASSISTED TREATMENT OF OPIOID USE DISORDER IN THE UNITED STATES: A COST-UTILITY ANALYSIS

    May 1, 2020, 00:00
  • PDB59 THE IMPACT OF HYPERKALAEMIA AND ITS CONCURRENCE WITH CARDIORENAL COMORBIDITIES ON HEALTHCARE RESOURCE USE IN THE UK

    May 1, 2020, 00:00
  • PMU60 DO COMPANIES SEQUENCE THE LAUNCH OF INDICATIONS FOR MULTI-INDICATION PRODUCTS?

    May 1, 2020, 00:00
  • Gastrointestinal Disorders - Economic Evaluation

    May 1, 2020, 00:00
  • PDG49 DETERMINANTS OF NON-PHARMACOLOGIC THERAPY, OPIOID, NON-OPIOID/OPIOID COMBINATION, AND NON-OPIOID MEDICATIONS IN OUTPATIENTS WITH NONMALIGNANT CHRONIC PAIN USING RECENT NATIONAL SURVEY

    May 1, 2020, 00:00
  • PIN79 VACCINATION COVERAGE RATE: WHAT CAN WE EXPECT FROM BRAZIL?

    May 1, 2020, 00:00
  • PIH29 ECONOMIC BURDEN OF ENDOMETRIOSIS: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00
  • Musculoskeletal Disorders - Health Technology Assessment

    May 1, 2020, 00:00
  • Patient Behavior Studies

    May 1, 2020, 00:00
  • PDB35 A COST MINIMIZATION ANALYSIS OF NEGATIVE PRESSURE WOUND THERAPY TECHNOLOGIES FOR THE TREATMENT OF MODERATE TO SEVERE FOOT INFECTIONS

    May 1, 2020, 00:00
  • PDG75 PREVALENCE AND FACTORS ASSOCIATED WITH ANTIEPILEPTIC DRUG USE IN NURSING HOME RESIDENTS WITH PAIN

    May 1, 2020, 00:00
  • PMU58 SMART SPENDING: REALLOCATING AMERICANS’ FOOD BUDGETS TO SAVE COSTS AND IMPROVE DIET QUALITY

    May 1, 2020, 00:00
  • Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the ISPOR Personalized Precision Medicine Special Interest Group [Editor's Choice]

    May 1, 2020, 00:00
  • PMS21 ANNUAL HEALTH INSURANCE TREATMENT COST OF INJURIES TO THE ELBOW AND FOREARM BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00
  • PIN78 CHARACTERIZATION OF UNNECESSARY EMERGENCY DEPARTMENT ENCOUNTERS FOR RABIES POSTEXPOSURE PROPHYLAXIS VACCINATION

    May 1, 2020, 00:00
  • PIN13 ESTIMATING THE IMPACT OF A GENDER-NEUTRAL QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN ALL HPV 6/11/16/18 -RELATED DISEASES IN COLOMBIA

    May 1, 2020, 00:00
  • PMU59 GLOBAL OUTCOMES-BASED CONTRACTING TRENDS IN THE US AND EUROPE OVER THE PAST 5 YEARS

    May 1, 2020, 00:00
  • PMH31 RISK OF FALLS AND FRACTURES ASSOCIATED WITH CONCOMITANT USE OF ACETYLCHOLINESTERASE INHIBITORS AND ATYPICAL ANTIPSYCHOTICS AMONG OLDER ADULTS WITH DEMENTIA

    May 1, 2020, 00:00
  • PDB47 ANNUAL HEALTH INSURANCE TREATMENT COST OF NON-INSULIN-DEPENDENT DIABETES WITH COMPLICATIONS BASED ON ROUTINELY COLLECTED FINANCING DATA

    May 1, 2020, 00:00
  • PIN15 BUDGETARY IMPACT ANALYSIS OF SHORTENING TREATMENT FOR MULTIDRUG-RESISTANT TUBERCULOSIS IN BRAZIL

    May 1, 2020, 00:00
  • Individual's Health - Patient-Centered Research

    May 1, 2020, 00:00
  • Injury Information Systems

    May 1, 2020, 00:00
  • PMU3 EFFECTIVENESS OF IMPLEMENTATION OF ANTIMICROBIAL STEWARDSHIP PROGRAMMES IN INDIA: EVIDENCE FROM SYSTEMATIC REVIEW AND META-ANALYSIS

    May 1, 2020, 00:00
  • PIH8 UNDERSTANDING THE ECONOMIC BURDEN OF COMORBIDITIES ASSOCIATED WITH MALE HYPOGONADISM: A COST MODEL IN ENGLAND

    May 1, 2020, 00:00
  • Multiple Diseases - Epidemiology Public Health

    May 1, 2020, 00:00
  • PIH71 RISK FACTORS ASSOCIATED WITH FALLS AMONG THE ELDERLY IN U.S.: AN ANALYSIS OF MEDICARE CURRENT BENEFICIARY SURVEY DATA

    May 1, 2020, 00:00
  • PMH34 INTEGRATING COUNTY-LEVEL HEALTH, HUMAN SERVICES, AND CRIMINAL JUSTICE DATA TO PREDICT RISK OF OPIOID OVERDOSE AMONG MEDICAID BENEFICIARIES: A MACHINE LEARNING APPROACH

    May 1, 2020, 00:00
  • Diabetes/Endocrine/Metabolic Disorders - Epidemiology Public Health

    May 1, 2020, 00:00
  • PMS82 PHYSICAL PARAMETERS AND THE FUNCTIONAL STATE OF THE SPINE IN AMATEUR TENNIS PLAYERS

    May 1, 2020, 00:00
  • Biologics/Biosimilars/Regenerative Medicine - Real World Data Information Systems

    May 1, 2020, 00:00
  • PGI16 BREAKDOWN OF COSTS ATTRIBUTABLE TO CLOSTRIDIOIDES DIFFICILE INFECTION IN THE US: RESULTS FROM A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00
  • Cardiovascular Disorders - Patient-Centered Research

    May 1, 2020, 00:00
  • The EQ-5D-5L Value Set for England: Response to the “Quality Assurance”

    May 1, 2020, 00:00
  • AI2 PREDICTORS OF PARKINSON DISEASE IN A MEDICARE POPULATION: AN APPLICATION OF MACHINE LEARNING IN EARLY DISEASE DETECTION

    May 1, 2020, 00:00
  • PMH39 ECONOMIC BURDEN ASSOCIATED WITH MAJOR DEPRESSIVE DISORDER, GLOBAL ANXIETY DISORDER, AND POLY-NONCOMMUNICABLE CHRONIC DISEASE (NCCD) COMORBIDITY

    May 1, 2020, 00:00
  • PMD22 BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF MECHANICAL THROMBECTOMY WITH STENT RETRIEVERS AFTER THROMBOLYSIS IN ISCHEMIC-STROKE WITH LARGE VESSEL OCCLUSION IN THE CHILEAN PUBLIC SECTOR.

    May 1, 2020, 00:00
  • PMU26 COST-UTILITY ANALYSIS OF CANCER AND NON-CANCER CONDITIONS: A SYSTEMATIC REVIEW OF DIFFERENT LEVELS OF DISEASE PREVENTION AND CONTROL, 1990 TO 2016

    May 1, 2020, 00:00
  • PCN4 ACCURACY OF LIFE YEAR GAIN PREDICTIONS FOR NIVOLUMAB MONOTHERAPY IN THE LONG TERM: AN ANALYSIS ACROSS FOUR INDICATIONS

    May 1, 2020, 00:00
  • PIT4 ECONOMIC BURDEN OF HOSPITALIZATIONS RELATED TO MAJOR AND MEDIUM BURN INJURIES IN BRAZIL

    May 1, 2020, 00:00
  • PBI10 BUDGET IMPACT ANALYSIS OF MEPOLIZUMAB AS AN ADD-ON THERAPY IN THE TREATMENT OF SEVERE EOSINOPHILIC ASTHMA IN CHILE

    May 1, 2020, 00:00
  • PBI2 EFFICACY AND SAFETY OF BIOLOGICS FOR THE TREATMENT OF ADULT PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS IN RUSSIA: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

    May 1, 2020, 00:00
  • «
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39 (current)
  • 40
  • »